Author: Kayaaslan, Bircan; Eser, Fatma; Kaya Kalem, AyÅŸe; Bilgic, Zeynep; Asilturk, Dilek; Hasanoglu, Imran; Ayhan, Muge; Tezer Tekce, Yasemin; Erdem, Deniz; Turan, Sema; Mumcuoglu, Ipek; Guner, Rahmet
Title: Characteristics of candidemia in COVIDâ€19 patients; increased incidence, earlier occurrence and higher mortality rates compared to nonâ€COVIDâ€19 patients Cord-id: 8xluzhzz Document date: 2021_6_16
ID: 8xluzhzz
Snippet: Severe COVIDâ€19 patients in ICU are at high risk for candidemia due to exposure to multiple risk factors for candidemia. We aimed to compare the incidence of candidemia in ICU patients with and without COVIDâ€19, and to investigate epidemiologic and clinical characteristics of candidemia patients and risk factors for mortality in candidemia patients. This retrospective study was conducted in patients followed in the ICUs of Ankara City Hospital for 2 years, divided into preâ€pandemic and pan
Document: Severe COVIDâ€19 patients in ICU are at high risk for candidemia due to exposure to multiple risk factors for candidemia. We aimed to compare the incidence of candidemia in ICU patients with and without COVIDâ€19, and to investigate epidemiologic and clinical characteristics of candidemia patients and risk factors for mortality in candidemia patients. This retrospective study was conducted in patients followed in the ICUs of Ankara City Hospital for 2 years, divided into preâ€pandemic and pandemic periods. The incidence (event per 1000 patientâ€days) and epidemiology of candidemia, clinical and laboratory characteristics of patients were compared in COVIDâ€19 and nonâ€COVIDâ€19 groups. Candidemia incidence was higher in the COVIDâ€19 group (2.16, 95% CI 1.77–2.60) than the nonâ€COVIDâ€19 group (1.06, 95% CI 0.89–0.125) (p < .001). A total of 236 candidemia episodes (105 in COVIDâ€19 patients and 131 in nonâ€COVIDâ€19 patients) were detected during the study periods. COVIDâ€19 cases had a higher rate of corticosteroid use (63.8% vs. 9.9%, p < .001). Epidemiology of candidemia and antifungal susceptibility were similar. Candidemia developed 2 weeks earlier in COVIDâ€19 groups and resulted in higher mortality (92.5% vs. 79.4%, p .005). Oneâ€third of candidemia patients died before receiving any antifungal treatment, and this rate was higher in the COVIDâ€19 group. In multivariate logistic regression analysis, corticosteroid use, presence of sepsis and age older than 65 years were independent risk factors for mortality in candidemia patients. Candidemia with high mortality is a more serious problem for COVIDâ€19 patients due to its increased incidence, earlier occurrence and a higher rate of mortality.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date